Enhanced Medical Nutrition (EMN) develops medical nutrition products and programs to improve surgical outcomes. Its flagship product, ENROUTE®, is a proprietary, evidence-based nutrition program for the dietary management of surgery, supported by clinical evidence and built on patented technology licensed from university inventors. ENROUTE® is administered pre- and post-operatively, tailored to address surgical patients' metabolic and physiological demands, and currently focuses on adult orthopedic surgery populations. EMN intends to scale ENROUTE® across North America using proceeds from its recent financing. The company is based in Toronto, Ontario and Chicago, Illinois. EMN aims to integrate nutrition into surgical protocols to reduce risk, accelerate recovery, and improve patient experience.

Total raised

$5M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2025